A recent Federal Circuit ruling offers timely guidance for life sciences and biopharma companies on when and how to patent around clinical trials
Explicit Prescribing Information Guidance The prescribing information for branded medications containing semaglutide (like Wegovy) and tirzepatide (like Zepbound) explicitly advises against co-administration with other GLP-1 receptor agonists or tirzepatide-containing products
The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
Mechanisms of action: two distinct cascades BPC-157: NO pathway modulation and growth factor expression Preclinical studies have suggested that BPC-157 acts primarily through three axes: NO (nitric oxide) pathway : BPC-157 modulates endothelial NO signaling, favoring local vasodilation and perfusion of injured tissues VEGF-R2 expression and angiogenesis : animal models have shown increased formation of new capillaries at the injury site Interactions with dopaminergic, serotonergic and GABAergic pathways : BPC-157 exhibits a pleiotropic profile influencing neurological and digestive healing Documented strengths (animal models): healing of tendons, ligaments, gastrointestinal mucosa, bone, teeth, vessels, cornea
MySelf Wellness is an incredible place of healing
W.WangJ.RenQ
